Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SALMETEROL vs SATRALIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SALMETEROL vs SATRALIZUMAB: Safety Overview

Metric SALMETEROL SATRALIZUMAB
Total FAERS Reports 1,761 219
Deaths Reported 263 16
Death Rate 14.9% 7.3%
Hospitalizations 487 108
Average Patient Age 65.5 yrs 51.6 yrs
% Female Patients 68.4% 82.1%
FDA Approval Date Feb 4, 1994 N/A
Manufacturer GlaxoSmithKline LLC Genentech, Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Discontinued Prescription